PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 2026Clinical and Translational Gastroenterology0 citationsOpen Access

Body Mass Index (BMI) Dependent Effect of Glucagon Like Peptide 1 Receptor Agonist (GLP-1RA) Therapy on Bowel Preparation Quality

View Full Paper
FVFNU VikashSVSara Osorio ValenciaQYQijun Yang

Key Points

  • This research aims to evaluate how body mass index (BMI) influences the effectiveness of GLP-1RA therapy on bowel preparation quality.
  • Analyzed the effects of GLP-1RA therapy on bowel preparation quality among different BMI categories.
  • Stratified patients into normal, overweight, and severe obesity groups for comparison.
  • Assessed the incidence of inadequate bowel preparation across these groups.
  • Inadequate bowel preparation was notably higher in normal and overweight patients using GLP-1RA.
  • Minimal impact on bowel preparation quality was found in severely obese patients.
  • BMI stratification offers a framework for tailoring colonoscopy preparation.

Abstract

GLP-1RA therapy increased inadequate bowel preparation risk primarily in normal and overweight patients, with minimal effect in severe obesity. BMI stratification may inform personalized colonoscopy preparation strategies in GLP-1RA treated patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vikash et al. (2026) studied this question.

synapsesocial.com/papers/69df2b04e4eeef8a2a6aff07https://doi.org/10.14309/ctg.0000000000001037
Ask AI
Helpful
Bookmark
Share
View Full Paper